FORWARD-MORPHOLOGICAL CRITERIA OF ULCERATIVE COLITIS RELAPSE AND CONTINUOUS FLOW IN CHILDREN

Cover Page

Abstract


Inflammatory bowel disease is one of the most difficult groups of pathologies in pediatric gastroenterology, due to the steady growth of their prevalence, offset debut at an earlier age, the increase in the incidence of severe complicated forms. Established clinical, genetic, serologic criteria for progression of ulcerative colitis are contradictory, and some - the reach of most medical institutions. Aim: to evaluate the prognostic significance of morphological features of ulcerative colitis relapse and continuous flow. Materials and methods: a retrospective study conducted histological kolonobioptatov 26 children with recurrent, 20 - with a continuous flow of ulcerative colitis during their primary treatment in a hospital, the comparison group consisted of 50 children without inflammatory bowel disease. Results: morphological characteristics identified predictors of recurrent ulcerative colitis in the form of severe eosinophilic infiltration of the epithelium, lamina propria of the mucosa. For a continuous flow was characterized: high density cell infiltration of the lamina propria mucosa epithelium predominantly under represented plasma cells, fibroblasts, sclerosis of the basal membrane, the presence of epithelial arcades deformed crypt abscesses. Conclusion: the extended study of biopsy material, including assessment of the composition and location of infiltration, fibroblast pool of epithelial- connective relationships in the colonic mucosa of children with ulcerative colitis will not only assess the inflammatory process, but also to predict the course of disease, thereby defining a long-term tactics treatment.

 


E. N. Fedulova

Nizhny Novgorod Research Institute of Pediatric Gastroenterology, Russian Federation

Author for correspondence.
Email: fedulova04@mail.ru

Russian Federation MD, Head of the Department of large bowel pathology clinic of FSBI “Nizhny Novgorod Research Institute of Pediatric Gastroenterology” of the Ministry of Health of Russian Federation. Address: 22, Semashko St., Nizhny Novgorod, 603950, tel.: (831) 436-67-06

E. A. Zhukova

Nizhny Novgorod Research Institute of Pediatric Gastroenterology, Russian Federation

Email: fedulova04@mail.ru

Russian Federation PhD, professor, Deputy director of scientific work of FSBI “Nizhny Novgorod Research Institute of Pediatric Gastroenterology” of the Ministry of Health of Russian Federation. Address: 22, Semashko St., Nizhny Novgorod, 603950, tel.: (831) 436-62-46

T. A. Kuznetsova

Nizhny Novgorod Research Institute of Pediatric Gastroenterology, Russian Federation

Email: fedulova04@mail.ru

Russian Federation MD, research scientist of the Morphological Laboratory of FSBI “Nizhny Novgorod Research Institute of Pediatric Gastroenterology” of the Ministry of Health of Russian Federation. Address: 22, Semashko St., Nizhny Novgorod, 603950, tel.: (831) 436-93-39

O. V. Shumilova

Nizhny Novgorod Research Institute of Pediatric Gastroenterology, Russian Federation

Email: shumilovaolya0502@mail.ru

Russian Federation junior research scientist of the Department of large bowel pathology clinic of FSBI “Nizhny Novgorod Research Institute of Pediatric Gastroenterology” of the Ministry of Health of Russian Federation. Address: Semashko St., 22, Nizhny Novgorod, 603950, tel.: (831) 436-67-06

O. V. Fedorova

Nizhny Novgorod Research Institute of Pediatric Gastroenterology, Russian Federation

Email: olgafedorva@mail.ru

Russian Federation senior research scientist the Department of large bowel pathology clinic of FSBI “Nizhny Novgorod Research Institute of Pediatric Gastroenterology” of the Ministry of Health of Russian Federation. Address: 22, Semashko St., Nizhny Novgorod, 603950, tel.: (831) 436-67-06

O. A. Tutina

Nizhny Novgorod Research Institute of Pediatric Gastroenterology, Russian Federation

Email: tutina_oa@mail.ru

Russian Federation MD, research scientist of the Department of large bowel pathology clinic of FSBI “Nizhny Novgorod Research Institute of Pediatric Gastroenterology” of the Ministry of Health of Russian Federation. Address: 22, Semashko St., Nizhny Novgorod, 603950, tel.: (831) 436-67-06

  1. Baranov A.A., Potapov A.S., Tsimbalova E.G. Modern technology diagnosis and treatment of inflammatory bowel disease in children. Vestnik Rossiiskoi akademii meditsinskikh nauk – Annals of the Russian Academy of Medical Sciences. 2011; 6: 36–41.
  2. Cucchiara S., Latino A., Palmieri O. Role of CARD 15, DLG5, OCTN genes polymorphisms in children with inflammatory bowel disease. World J. Gastroenterol. 2007; 13 (8):1221–1229.
  3. Ferraris A., Torres B., Knafelz D. Relationship betweenNOD2/CARD15, SLC22A4/5, DLG5 polymorphisms and ealy-oncet inflammatory bowel disease: an Italian multicentric study. Inflamm. Bow. Dis. 2006; 12 (5): 355–361.
  4. Cukovic-Cavka S., Vermeire S., Hrstic I. NOD2/CARD15 mutations in Croatian pations with Crohn's disease: prevalence and genotypephenjtype relationship. Eur. J. Gastroenterol. Hepatol. 2006; 18 (8): 895–899.
  5. Shumilov P.V. Patogeneticheskie faktory razvitiya i techeniya bolezni Krona i nespetsificheskogo yazvennogo kolita u detei. Avtoref. dis. …. kand. med. nauk [Pathogenetic Development Factors and Progression of Crohn Disease and Nonspecific Ulcerative Colitis in Children. Author’s abstract]. Мoscow, 2010. 50 p.
  6. Turner D., Mack D.R., Hyams J. et al. C-reactive protein (CRP), reythrocyte sedimentation rate (ESR) or both? A systematic evalution in pediatric ulcerative colitis. J. Crohns Colitis. 2011; 5: 423–429.
  7. Turner D., Leach S.T., Mack D. et al. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response. Gut. 2010; 59: 1207–1212.
  8. Lewis J.D. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011; 140: 1817–1826.
  9. Vermeire S., Van Assche G., Rutgeerts P. Role of genetics in prediction of disease course and response to therapy. World. J. Gastroenterol. 2010; 16: 2609–2615.
  10. Dubinsky M.C. Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease. World J. Gastroenterol. 2010; 16: 2604–2608.
  11. Amre D.K., Lu S.E., Costea F. et al. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am. J. Gastroenterol. 2006; 101: 645–652.
  12. Ferrante M., Henckaerts L., Joossens M. et al. New serological markers in inflammatory bowel disease are associated with complicated disease behavior. Gut. 2007; 56: 1394–1403.
  13. Travis S.P., Schnell D., Krzeski P. et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut. 2012; 61: 535–542.
  14. Fedulova E.N., Tutina O.A., Fedorova O.V., Potekhin P.P., Kopeikin V.N. Pediatricheskaya farmakologiya – Pediatric Pharmacology. 2009; 6 (3): 111–119.
  15. Potekhin P.P., Fedulova E.N., Kopeikin V.N., Bogomolov A.R., Lukoyanova G.M., Tutina O.A. Sposob prognozirovaniya techeniya yazvennogo kolita u detei. Patent № 2287817 Ross. Federatsiya MPK G01N33/483 (2006.01). Zayavitel' i patentoobladatel': "Nizhegorodskii nauchno-issledovatel'skii institut detskoi gastroenterologii" № 2004127304/15. Zayav.: 13.09.2004. Opubl.: 20.11.2006 [Prognosis Method of the Ulcerative Colitis Progression in Children. Patent No. 2287817 of the Russian Federation MPK G01N33/483 (2006.01). Applicant and patent holder: “Nizhny Novgorod Research Institute of Pediatric Gastroenterology”. No. 2004127304/15. Applied: Sep 13, 2004. Published: Nov 20, 2006]. Nizhny Novgorod, 2006.

Views

Abstract - 32

PDF (Russian) - 12

Cited-By


PlumX

Dimensions



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies